DHI
35
4
MCO
68
4
MTCH
42
-4
UHS
60
4
AON
36
4
PLD
33
-4
WBA
43
-5
MS
69
3
RSG
53
3
VTR
35
4
ED
45
3
AA
38
-2
FE
44
3
MMM
47
2
XEL
51
8
K
65
2
AIZ
52
2
GRMN
52
6
LMT
29
7
ECL
54
5
DHI
35
4
MCO
68
4
MTCH
42
-4
UHS
60
4
AON
36
4
PLD
33
-4
WBA
43
-5
MS
69
3
RSG
53
3
VTR
35
4
ED
45
3
AA
38
-2
FE
44
3
MMM
47
2
XEL
51
8
K
65
2
AIZ
52
2
GRMN
52
6
LMT
29
7
ECL
54
5
Financhill
Back

Columbia Seligman Premium Technology Growth Fund Vs. Janux Therapeutics Industry Stock Comparison

Buy
59

STK
Columbia Seligman Premium Technology Growth Fund

Last Price:
$32.76
Seasonality Move:
3.85%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Buy
59
Columbia Seligman Premium Technology Growth Fund (STK) is a Buy

Is Columbia Seligman Premium Technology Growth Fund a Buy, Sell or Hold?

  • The current Columbia Seligman Premium Technology Growth Fund [STK] share price is $32.78. The Score for STK is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • STK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

STK Stock Price Chart

What is Columbia Seligman Premium Technology Growth Fund's stock price today?

  • The Columbia Seligman Premium Technology Growth Fund share price today is $32.78
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STK is experiencing slight selling pressure.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

STK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.33 Sell
Relative Strength Index (14 RSI): 47.54 Sell
Chaikin Money Flow: -5673 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (31.85 - 34.93) Sell
Bollinger Bands (100): (32.07 - 34.07) Sell

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

STK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.47 Buy
20-day SMA: 32.97 Sell
50-day SMA: 33.41 Sell
200-day SMA: 32.6 Buy
8-day EMA: 32.62 Buy
20-day EMA: 32.87 Sell
50-day EMA: 33.17 Sell
200-day EMA: 32.56 Buy

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

Columbia Seligman Premium Technology Growth Fund Earnings Growth & STK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

Columbia Seligman Premium Technology Growth Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):